These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29922274)

  • 1. Soluble Mediators Produced by Pro-Resolving Macrophages Inhibit Angiogenesis.
    Michaeli S; Dakwar V; Weidenfeld K; Granski O; Gilon O; Schif-Zuck S; Mamchur A; Shams I; Barkan D
    Front Immunol; 2018; 9():768. PubMed ID: 29922274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
    Zhu GS; Tang LY; Lv DL; Jiang M
    Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan.
    Yu Y; Chen R; Sun Y; Pan Y; Tang W; Zhang S; Cao L; Yuan Y; Wang J; Liu C
    Acta Biomater; 2018 Apr; 71():510-521. PubMed ID: 29501817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of auriculasin on vascular endothelial growth factor (VEGF)-induced angiogenesis via regulation of VEGF receptor 2 signaling pathways in vitro and in vivo.
    Cho HD; Moon KD; Park KH; Lee YS; Seo KI
    Food Chem Toxicol; 2018 Nov; 121():612-621. PubMed ID: 30236598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endothelial cell secretome as a novel treatment to prime adipose-derived stem cells for improved wound healing in diabetes.
    Fromer MW; Chang S; Hagaman ALR; Koko KR; Nolan RS; Zhang P; Brown SA; Carpenter JP; Caputo FJ
    J Vasc Surg; 2018 Jul; 68(1):234-244. PubMed ID: 28760584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
    Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study.
    Cao W; Li H; Zhang J; Li D; Acheampong DO; Chen Z; Wang M
    Protein Expr Purif; 2013 Aug; 90(2):55-66. PubMed ID: 23680780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions.
    Na HJ; Hwang JY; Lee KS; Choi YK; Choe J; Kim JY; Moon HE; Kim KW; Koh GY; Lee H; Jeoung D; Won MH; Ha KS; Kwon YG; Kim YM
    Angiogenesis; 2014 Jan; 17(1):179-94. PubMed ID: 24097299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling.
    Liu Y; He Y; Yang F; Cong X; Wang J; Peng S; Gao D; Wang W; Lan L; Ying X; Liu M; Chen Y; Yi Z
    Sci China Life Sci; 2017 Feb; 60(2):202-214. PubMed ID: 28194552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.
    Nkembo AT; Ntantie E; Salako OO; Amissah F; Poku RA; Latinwo LM; Lamango NS
    Oncotarget; 2016 Oct; 7(42):68194-68205. PubMed ID: 27626690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human peripheral blood eosinophils induce angiogenesis.
    Puxeddu I; Alian A; Piliponsky AM; Ribatti D; Panet A; Levi-Schaffer F
    Int J Biochem Cell Biol; 2005 Mar; 37(3):628-36. PubMed ID: 15618019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Netrin-1 acts as a non-canonical angiogenic factor produced by human Wharton's jelly mesenchymal stem cells (WJ-MSC).
    Prieto CP; Ortiz MC; Villanueva A; Villarroel C; Edwards SS; Elliott M; Lattus J; Aedo S; Meza D; Lois P; Palma V
    Stem Cell Res Ther; 2017 Feb; 8(1):43. PubMed ID: 28241866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.
    Ledford KJ; Murphy N; Zeigler F; Bartel RL; Tubo R
    Stem Cell Res Ther; 2015 Mar; 6(1):25. PubMed ID: 25889271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
    Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
    J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arnebin-1 promotes the angiogenesis of human umbilical vein endothelial cells and accelerates the wound healing process in diabetic rats.
    Zeng Z; Zhu BH
    J Ethnopharmacol; 2014 Jul; 154(3):653-62. PubMed ID: 24794013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators.
    Hamsa TP; Kuttan G
    Drug Chem Toxicol; 2012 Jan; 35(1):57-70. PubMed ID: 22145808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoxanthohumol modulates angiogenesis and inflammation via vascular endothelial growth factor receptor, tumor necrosis factor alpha and nuclear factor kappa B pathways.
    Negrão R; Duarte D; Costa R; Soares R
    Biofactors; 2013; 39(6):608-22. PubMed ID: 23904052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.